These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 373905)

  • 1. Cardiotoxic effects of antitumor agents.
    Ghione M
    Cancer Chemother Pharmacol; 1978; 1(1):24-34. PubMed ID: 373905
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiotoxicity of chemotherapeutic agents: incidence, treatment and prevention.
    Pai VB; Nahata MC
    Drug Saf; 2000 Apr; 22(4):263-302. PubMed ID: 10789823
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anthracycline cardiotoxicity in breast cancer patients: synergism with trastuzumab and taxanes.
    Gianni L; Salvatorelli E; Minotti G
    Cardiovasc Toxicol; 2007; 7(2):67-71. PubMed ID: 17652806
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Chemotherapy and cardiotoxicity].
    Brestescher C; Pautier P; Farge D
    Ann Cardiol Angeiol (Paris); 1995 Oct; 44(8):443-7. PubMed ID: 8669796
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anthracycline-induced cardiotoxicity: course, pathophysiology, prevention and management.
    Barry E; Alvarez JA; Scully RE; Miller TL; Lipshultz SE
    Expert Opin Pharmacother; 2007 Jun; 8(8):1039-58. PubMed ID: 17516870
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiotoxicity of doxorubicin and other anthracycline derivatives.
    Jain D
    J Nucl Cardiol; 2000; 7(1):53-62. PubMed ID: 10698235
    [No Abstract]   [Full Text] [Related]  

  • 7. Dexrazoxane. A review of its use as a cardioprotective agent in patients receiving anthracycline-based chemotherapy.
    Wiseman LR; Spencer CM
    Drugs; 1998 Sep; 56(3):385-403. PubMed ID: 9777314
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Cardiologic sequelae of cytostatic therapy].
    Mladosievivcová B
    Cas Lek Cesk; 2001 Mar; 140(5):138-41. PubMed ID: 11347200
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New signal transduction paradigms in anthracycline-induced cardiotoxicity.
    Ghigo A; Li M; Hirsch E
    Biochim Biophys Acta; 2016 Jul; 1863(7 Pt B):1916-25. PubMed ID: 26828775
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The cardiotoxicity of chemotherapeutic drugs.
    Allen A
    Semin Oncol; 1992 Oct; 19(5):529-42. PubMed ID: 1411651
    [No Abstract]   [Full Text] [Related]  

  • 11. Clinical spectrum of anthracycline antibiotic cardiotoxicity.
    Bristow MR; Billingham ME; Mason JW; Daniels JR
    Cancer Treat Rep; 1978 Jun; 62(6):873-9. PubMed ID: 667861
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early heart transplant in a child with advanced lymphoma.
    Morgan E; Pahl E
    Pediatr Transplant; 2002 Dec; 6(6):509-12. PubMed ID: 12453205
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dexrazoxane for protection against cardiotoxic effects of anthracyclines in children.
    Lipshultz SE
    J Clin Oncol; 1996 Feb; 14(2):328-31. PubMed ID: 8636739
    [No Abstract]   [Full Text] [Related]  

  • 14. [Anthracycline-induced cardiotoxicity: monitoring and prevention of the lesion].
    Orditura M; De Vita F; Ciaramella F; Catalano G
    Ann Ital Med Int; 1994; 9(4):243-8. PubMed ID: 7893575
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Cardiotoxicity as undesired side effect in the treatment of breast cancer].
    Gramatyka M
    Postepy Hig Med Dosw (Online); 2014 May; 68():483-97. PubMed ID: 24864100
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardioprotection of trimetazidine and anthracycline-induced acute cardiotoxic effects.
    Pascale C; Fornengo P; Epifani G; Bosio A; Giacometto F
    Lancet; 2002 Mar; 359(9312):1153-4. PubMed ID: 11943290
    [No Abstract]   [Full Text] [Related]  

  • 17. [Preventing the cardiotoxic effects of anthracyclines with Cardioxane].
    Semiglazov VF
    Vopr Onkol; 1997; 43(6):569-74. PubMed ID: 9479353
    [No Abstract]   [Full Text] [Related]  

  • 18. [Anthracycline cardiotoxicity].
    Finolezzi E; Torromeo C; Vincenzi B; Avvisati G
    Clin Ter; 2003; 154(2):115-21. PubMed ID: 12856371
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A risk-benefit assessment of anthracycline antibiotics in antineoplastic therapy.
    Abraham R; Basser RL; Green MD
    Drug Saf; 1996 Dec; 15(6):406-29. PubMed ID: 8968695
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genotyping the risk of anthracycline-induced cardiotoxicity.
    Deng S; Wojnowski L
    Cardiovasc Toxicol; 2007; 7(2):129-34. PubMed ID: 17652817
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.